JUVÉDERM® ULTRA PLUS XC

Key Uses of Juvéderm^® Ultra Plus XC

Clinics can buy Juvéderm^® Ultra Plus XC online from Kinami Health to address specific structural corrections in patients with moderate-to-severe facial folds and localized volume loss. Its rheological profile allows it to provide both structural support and soft contouring when placed correctly.

Common treatment indications include:

• Nasolabial fold correction.
• Marionette line softening.
• Lower midface volume restoration.
• Jawline contour refinement in selected patients.
• Supportive correction in combination with rejuvenation protocols. Clinics frequently combine it with other dermal fillers to address multi-layer aging changes more comprehensively.

Manufacturing Information for Juvéderm^® Ultra Plus XC

Juvéderm^® Ultra Plus XC is manufactured by Allergan Aesthetics, an AbbVie company, in regulated facilities that comply with strict medical device quality and sterility standards.

The filler is produced using proprietary HYLACROSS^® hyaluronic acid cross-linking technology, designed to create a smooth, cohesive gel with predictable viscosity, elasticity, and dermal integration.

Expected Benefits and Results of the Treatments

Patients treated with this filler often experience immediate improvement in the appearance of deep folds and facial volume deficits. Practitioners who want to compare viscosities, indications, and gel characteristics can review the full Juvéderm range available online when planning individualized correction strategies.

Additional clinical benefits may include:

• Restoration of structural support in areas affected by age-related tissue descent.
• Improvement in facial harmony through targeted volume placement.
• Enhanced skin hydration due to the hygroscopic nature of hyaluronic acid.
• Gradual softening of etched lines as the gel integrates with surrounding tissue.
• Increased patient satisfaction when used in comprehensive rejuvenation protocols.

Treatment outcomes depend on practitioner expertise, anatomical considerations, and realistic patient expectations. Proper injection depth and product selection play an important role in ensuring consistent aesthetic performance.

Juvéderm^® Ultra Plus XC Key Ingredients and Device Properties

The formulation centers on cross-linked hyaluronic acid, a molecule known for its ability to retain moisture and provide mechanical support within the skin. Lidocaine is incorporated to reduce procedural discomfort and support patient tolerance.

Important formulation features include:

• 24 mg/mL of cross‑linked hyaluronic acid gel matrix.
• 3 mg/mL of Lidocaine.
• Smooth consistency that facilitates even distribution.
• Cohesive structure that helps maintain placement integrity.

Included Items or Accessories

Each product package is prepared for clinical use and supports precise administration by trained practitioners. Depending on the distribution configuration, accessory components may vary. Many practitioners prefer sourcing technique-specific cannulas and needles separately to match their injection approach.

Typical package contents include:

• 2 × 1 mL pre-filled sterile syringes containing dermal filler gel.
• 4 × 27G cannulas intended for controlled and accurate product placement.
• Product labeling and traceability documentation.
• Instructions for professional use.

Administration Method for Juvéderm^® Ultra Plus XC

This dermal filler is administered via intradermal or subdermal injection, depending on the depth of correction and treatment goals. Proper anatomical assessment and product placement technique are essential for achieving balanced and natural-looking results.

Common administration approaches include:

• Linear threading for softening deep folds.
• Serial puncture for targeted volume placement.
• Fanning technique for broader contour correction.
• Layered injections when both lift and surface refinement are required.

Guidelines for Proper Aftercare

Structured aftercare plays a key role in maintaining optimal filler positioning and supporting tissue recovery after injection. Providing clear written and verbal instructions helps patients understand how to protect results during the early healing phase.

Recommended aftercare considerations include:

• Avoiding excessive facial pressure, including massage or sleeping face down.
• Limiting strenuous physical activity for at least 24 hours after treatment.
• Postponing sauna visits, hot baths, or intense sun exposure temporarily.
• Using gentle skincare products that do not irritate recently treated areas.
• Applying cold compresses if mild swelling or discomfort develops.
• Maintaining adequate hydration to support tissue integration.

Patients should also be informed about expected timelines for swelling resolution and visible improvement. Follow-up appointments allow practitioners to assess symmetry, perform minor refinements if needed, and reinforce long-term treatment planning.

Potential Risks and Side Effects

Injection-based treatments may cause localized reactions as the tissue responds to the product placement. Most effects are temporary and resolve without intervention when the appropriate technique and aseptic protocols are followed.

Possible side effects may include:

• Mild to moderate swelling during the first few days after treatment.
• Injection site redness or sensitivity linked to mechanical tissue disruption.
• Bruising, particularly in highly vascular facial zones.
• Palpable nodules or uneven distribution requiring massage or minor correction.
• Temporary firmness as the gel settles into the treatment plane.

Although uncommon, more serious complications can occur if filler is injected intravascularly or placed in anatomically high-risk areas. Practitioners must remain prepared to recognize early warning signs and initiate appropriate management strategies.

Juvéderm^® Ultra Plus XC Treatment Contraindications

Treatment with Juvéderm^® Ultra Plus XC is not appropriate for every patient. Careful assessment of medical history, skin condition, and treatment goals should always be completed before planning an injection.

Contraindications and precautionary considerations include:

• Known hypersensitivity to hyaluronic acid, Lidocaine, or gram-positive bacterial proteins.
• Active infections, inflammatory skin conditions, or open wounds at the intended injection site.
• Tendency toward hypertrophic scarring or keloid formation.
• Ongoing anticoagulant therapy that may increase bruising or bleeding risk.
• Pregnancy or breastfeeding, where elective aesthetic procedures are typically postponed.
• Recent laser resurfacing, chemical peeling, or other aggressive skin treatments requiring healing time.

In cases where this product is not ideal, clinicians may consider other options within the wider category of hyaluronic acid dermal fillers. Additionally, to absolute contraindications, practitioners should evaluate psychological readiness, treatment motivation, and patient compliance with aftercare recommendations. Careful screening supports safer outcomes and helps maintain professional standards within aesthetic practice.